Last updated on October 2018

Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer


Brief description of study

The purpose of study is to compare the efficacy and safety of ONO-4538 in combination with carboplatin, paclitaxel, and bevacizumab (ONO-4538 group) to placebo in combination with carboplatin, paclitaxel, and bevacizumab (placebo group) in chemotherapy-nave subjects with stage IIIB/IV or recurrent non-squamous non-small cell lung cancer unsuitable for radical radiation in a multicenter, randomized, double-blind study.

Clinical Study Identifier: NCT03117049

Contact Investigators or Research Sites near you

Start Over

Ono Pharmaceutical Co. Ltd Corporate ...

Osaka Clinical Site
Toyonaka, Japan
  Connect »

Ono Pharmaceutical Co. Ltd Corporate ...

Hyogo Clinical Site
Amagasaki, Japan
4.87miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.